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Abstract
The recent design of ultra-broadband, multi-frequency ultrasound transducers has enabled high 
sensitivity, high-resolution contrast imaging, with very efficient suppression of tissue background 
using a technique called acoustic angiography. Here we perform the first application of acoustic 
angiography to evolving tumors in mice predisposed to develop mammary carcinoma, with the 
intent of visualizing and quantifying angiogenesis progression associated with tumor growth. 
Metrics compared include vascular density and two measures of vessel tortuosity quantified from 
segmentations of vessels traversing and surrounding 24 tumors and abdominal vessels from 
control mice. Quantitative morphological analysis of tumor vessels demonstrated significantly 
increased vascular tortuosity abnormalities associated with tumor growth with the distance metric 
elevated approximately 14% and the sum of angles metric increased 60% in tumor vessels versus 
controls. Future applications of this imaging approach may provide clinicians a new tool in tumor 
detection, differentiation, or evaluation, though with limited depth of penetration using the current 
configuration.
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Ultrasound imaging has several advantages over other modalities in the clinic such as low 
cost, portability, safety, and real-time imaging capability. However, grayscale ultrasound 
suffers from speckle noise and has poor sensitivity to blood flow in small vessels. Contrast-
enhanced ultrasound (CEUS) utilizes administration of a microbubble contrast agent to 
enhance imaging sensitivity to blood flow, and is primarily utilized for enhanced delineation 
of the left ventricle in echocardiography. Quantitative CEUS imaging, including techniques 
such as wash-in and wash-out curves have been widely utilized in oncology imaging 
because of the involvement of vascular networks in tumor progression (Quaia 2011). 
Current CEUS imaging is performed at clinically-relevant frequencies between 1-12 MHz, 
and utilizes techniques such as pulse-inversion and amplitude-modulation in order to 
enhance detection of microbubbles and reduce tissue background (Averkiou et al. 2003; 
Martin and Dayton 2013). However, these strategies also limit both the resolution and 
contrast-to-tissue ratio of existing CEUS imaging.
Acoustic angiography is a significant advance in contrast-enhanced ultrasound (CEUS) 
imaging made possible by the application of dual-frequency ultrasound transducers, which 
as of yet are still only available as prototype devices (Gessner et al. 2013). In acoustic 
angiography imaging, microbubble contrast agents are excited by a low frequency 
ultrasound transducer element, similar to those used in clinical imaging (2-4 MHz), yet 
imaging data is received with a second transducer at a much higher frequency, e.g. 25-30 
MHz using the technology described here. The excited microbubbles produce broadband 
superharmonic energy, which can be detected with the high frequency receiver, whereas 
tissue scatters almost negligible energy at this frequency (Kruse and Ferrara 2005). This 
dual-frequency approach results in images of the contrast agent only (flowing through the 
microvessels) with very minimal if any tissue background. The resulting images obtained 
with this new technique demonstrate images of blood vessel morphology entirely unlike 
standard B-mode ultrasound and resembling x-ray angiograms, thus leading us to refer to 
this technique as "acoustic angiography". An additional substantial advantage is that the 
dual-frequency approach enables resolution as dictated by the high frequency receiver, 
although this also provides a limitation in penetration depth due to (one-way) attenuation of 
high frequency signals from the microbubbles (Lindsey et al. 2014). Figure 1 depicts a side-
by-side comparison of B-mode and acoustic angiography (maximum intensity projection) 
images of the same tissue volume, approximately 2.5 by 2.5 cm, in the coronal view, 
illustrating the advantages of acoustic angiography in assessing microvascular structure.
Because acoustic angiography can image microvessel structure, it is an ideal tool for 
visualizing abnormal vascular morphology resulting from cancer angiogenesis. 
Angiogenesis is the process of new vascular growth, which is a necessary process for 
physiologic events such as wound healing (Nissen et al. 1998), but escapes normal 
pathologic control during tumor development. Malignant angiogenesis is so pervasive across 
different types of tumors that it is one of Hanahan and Weinberg’s “Hallmarks of Cancer” 
(Hanahan and Weinberg 2011). Judah Folkman was one of the first researchers to realize the 
importance of angiogenesis in cancer and posited that tumors would not grow beyond 2-3 
mm in size without neovascularization (Folkman 1971), and the present work will show that 
Shelton et al. Page 2













2-3 mm tumors do indeed show quantifiable angiogenesis in the mouse model chosen. A 
number of mechanisms of tumor angiogenesis exist, driven by different pro-angiogenic 
growth factors and molecular pathways (Carmeliet and Jain 2011). However, the end result 
of such abundant pro-angiogenic processes is a vascular network that is abnormal in both 
form and function. Tumor vessel networks lack the ordered, hierarchical branching networks 
found in normal tissue; vessels are leaky, tortuous, and have unpredictable relationships 
between size and flow rate (Jain et al. 2014). The angiogenic factors produced by tumors 
(such as vascular endothelial growth factor, or VEGF) often cause increased vessel 
diameter, vascular density, permeability, as well as alterations in vessel structure (Jain 2005; 
Jain 2014). Acoustic angiography has the unique potential to improve visualization and 
quantification of some of these angiogenic changes.
The microvascular maps produced by acoustic angiography have sufficient contrast and 
detail that computerized segmentation using multi-scale ridge traversal for centerline 
extraction (Aylward and Bullitt 2002) can be used to define the spatial coordinates occupied 
by individual vessels. From the spatial coordinates, the “curvedness”, or tortuosity, of the 
vessels can be computed, enabling the definition of multiple descriptions of vessel shape. It 
is the quantification of these tortuosity metrics which provides a new way to describe tumors 
using ultrasound imaging (Gessner et al. 2012). Tortuosity associated with malignancy has 
been used previously with other imaging modalities such as magnetic resonance 
angiography (MRA), photoacoustic tomography, microscopy, and computed tomography 
(CT) (Jain 2003; Bullitt et al. 2004; Bullitt et al. 2005b; Bullitt et al. 2006; Badea et al. 
2008; Laufer et al. 2012; Sodi et al. 2013). However, ultrasound applications of tortuosity 
metrics have primarily been limited to quantification of skeletonizations from intensity 
thresholding of Doppler ultrasound images (Huang et al. 2008; Molinari et al. 2010; Chang 
et al. 2012; Molinari et al. 2014). These types of images lack the clear vessel structures 
visible in acoustic angiography which make segmentation and analysis of tortuosity in 
individual vessels possible.
This study uses animal models to study vascular reformation associated with basal breast 
cancer. Basal breast cancer was chosen because it represents a significant disease burden 
and current diagnostic imaging suffers from poor specificity. Additionally, the breast 
provides an attractive target for the clinical translation of acoustic angiography imaging of 
lesions within a few centimeters of the skin surface (Feig et al. 1977). The vascular images 
produced by acoustic angiography offer the potential to identify malignant lesions through 
the quantification of the fundamental biologic process of cancer angiogenesis, and to 
become a useful clinical tool for evaluating suspicious lesions and for monitoring patients 
with known pathologies. The focus of the following studies is to demonstrate that tortuosity 
measures are higher than control levels in the smallest tumors palpable in mouse mammary 
pads (2-3 mm), and to explore how these metrics are related to tumor size.
Materials and Methods
Animal studies were approved by the University of North Carolina Institutional Animal 
Care and Use Committee. The UNC Lineberger Comprehensive Cancer Center's Mouse 
Phase I Unit (MP1U) provided C3(1)/Tag mice that are genetically engineered models of 
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basal breast cancer. Tumors are formed spontaneously in the mammary pad due to 
inactivation of the p53 and Rb (retinoblastoma) genes by the Simian Virus 40 large T 
antigen (Duncan et al. 2012). Control mice were female littermates not carrying the tumor 
suppressor gene inactivation to provide age, sex, and species matched controls.
Imaging was performed after anesthetizing the mice with vaporized isoflurane and placing 
them on a heated stage in the supine position. The abdomen was shaved and depilated, and 
ultrasound gel was applied to couple the transducer to the skin. Ultrasound images were 
acquired on a Vevo 770 ultrasound scanner (VisualSonics, Toronto, CA) with modified 
RMV 707 (30 MHz) or RMV 710B (25 MHz) transducers with 4 MHz annular transducers 
added for microbubble excitation in dual-frequency mode (Gessner et al. 2010). B-mode 
images of the inguinal mammary pads were acquired with the high frequency transducer, 
and the B-mode images were used to measure the dimensions of each tumor. The maximum 
imaging depth of all images acquired was 2.5 cm, which was more than adequate for 
visualization of mouse mammary pads and all tumors. Frame rate (4.5 frames per second) 
and inter-frame step size (100 microns) was kept consistent for all images acquired in this 
study.
Dual-frequency mode was used to acquire acoustic angiography images immediately 
following the acquisition of B-mode images, exciting the low frequency element with a 
single-cycle, inverted sinusoidal pulse to produce a transmit pulse with a mechanical index 
(MI) of approximately 0.6, and using the high frequency element to receive only.
Lipid-encapsulated microbubble contrast agents containing decafluorobutane (SynQuest 
Labs, Alachua, FL) were prepared with a (9:1) molar mixture of 1,2-distearoyl-sn-glycero-3-
phosphocholine (DSPC, Avanti Polar Lipids, Alabaster, AL), and 1,2-distearoyl-sn -
glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-2000] (mPEG-DSPE, 
Creative PEGWorks, Winston Salem, NC) and phosphate-buffered saline in phosphate-
buffered saline containing 15% (v/v) propylene glycol and 5% (v/v) glycerol, as described 
previously (Feingold et al. 2010). The lipid solution was agitated with a Vialmix mixer 
(Bristol-Myers Squibb Medical Imaging, North Billerica, MA) to create microbubbles which 
were infused through a tail-vein catheter at a rate of 1.5×108 bubbles/minute during acoustic 
angiography imaging.
Two acoustic angiography frames were acquired at each location and averaged to provide 
modest image smoothing. The 100 micron elevational steps used to acquire a 3-D volume 
were linearly interpolated to form isotropic, 50 micron voxels using Matlab (The 
MathWorks Inc., Natick, MA). Individual vessels were segmented using the Aylward/Bullitt 
centerline extraction algorithm with manually-defined seed points (Aylward and Bullitt 
2002). Statistical analysis was performed in R (R Foundation for Statistical Computing, 
Vienna, Austria)(R Development Core Team 2012).
Vascular tortuosity within and surrounding a tumor can be defined in a number of ways for 
three-dimensional objects. For the analysis described here, we used two metrics to capture 
different types of tortuosity seen in abnormal angiogenesis, and described in detail by Bullitt 
et al. (Bullitt et al. 2003) First, the distance metric (DM) is calculated as the total path length 
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of a vessel, divided by the Euclidean distance between vessel endpoints. The DM has a 
minimum value of 1 for a vessel lying in a straight line and increases as the vessel deviates 
from straight. The DM is effective at measuring arching curves, but is less sensitive to high-
frequency, low-amplitude variations. For high-frequency curvature, such as sinusoidal or 
spiraling vessels, the sum of angles metric (SOAM) is more appropriate for measuring such 
tortuosity (Bullitt et al. 2005a), since low-amplitude, high-frequency tortuosity does not 
greatly increase the total length of the vessel (which would increase the DM), but contains 
areas of high local curvature, elevating the SOAM. The SOAM is the integral of curvature 
along the vessel skeleton, normalized by the path length, where the curvature is computed 
by summing the angle between successive triplets of points on the centerline of a segmented 
vessel.
The distance metric and sum of angles metric of segmented vessels from tumors and 
controls were compared using a two-sided t-test in R. Tumors were also classified into 3 size 
categories to establish vessel populations indicative of tortuosity distributions at different 
stages of tumor growth, using pooled vessel sets. In addition to the categorical size 
classification, the tortuosity of each tumor can be summarized using the mean tortuosity 
metric and plotting maximum tumor diameter versus tortuosity. Linear regression by the 
least-squares method was used to fit a line relating tumor size to the DM and the SOAM.
In addition to these morphological descriptions of angiogenesis-induced vascular alterations, 
vascular density is evident in the acoustic angiography images as bright enhancement in the 
tumor region due to an abundance of visible vessels as well as signal detected from 
microbubbles in sub-resolution vasculature (see Figure 2). Since acoustic angiography is 
highly effective at eliminating tissue signals and detecting signals from microbubble contrast 
agents, intensity thresholding can be used to calculate number of voxels containing contrast 
in a region of interest (ROI). The vascular density of a 3-D tumor tissue volume (volumetric 
vascular density, or VVD) was computed by creating a mask of the tumor region of interest 
(ROI) using the B-mode image, applying the ROI mask to the acoustic angiography image, 
and using an intensity threshold to compute the percent of voxels containing microbubble 
contrast agent. The VVD of each tumor was compared to the vascular density of tissue 
adjacent to the tumors by translating the ROI mask medially by a distance approximately 
equal to the diameter of the tumor. ROI masks of the “normal” tissue were maintained at a 
depth equal to the tumor masks to avoid any attenuation effects on image intensity, and the 
size and shape of the tumor ROIs were not altered in the spatial translation. Tumor and 
normal tissue VVD were compared in 19 tumors using a paired t-test. Five tumors were not 
included in the VVD analysis due to the tumor position making it difficult to place a 
satisfactory ROI in the normal tissue.
Results
Vessels were segmented from 24 tumor-bearing mice, with tumor ranging in size from 2.02 
to 6.86 mm in their largest dimension, as well as vessels from control images of healthy 
mice in the same age and size range as the tumor-bearing mice. Control images were 
acoustic angiography images of the left and right lower abdomen in the location of the 
inguinal mammary pads. Tumor size was determined by measuring the length, width, and 
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depth of each tumor in high-frequency B-mode images and tumors were grouped into 1 of 3 
size bins based on the largest dimension. The 2-3 mm tumors ranged in size from 2.02 to 
2.93 mm, with an average size of 2.47 mm. These small tumors are barely palpable to 
trained handlers, but visible with high frequency B-mode ultrasound. Tumors classified as 
3-4 mm ranged from 3.01 to 3.94 mm with an average size of 3.52 mm. Tumors larger than 
4 mm were grouped together and ranged from 4.13 to 6.86 mm with a mean of 5.07 mm in 
the maximum dimension. The total number of vessels segmented and analyzed was 2302, 
with 1556 of these vessels coming from control images. The number of vessels analyzed for 
each tumor size range increased with tumor size, resulting in an average of 21.0, 32.6, and 
38.3 vessels extracted for each 2-3 mm, 3-4 mm, and >4 mm tumor image, respectively.
Both metrics of tortuosity (DM and SOAM) and the VVD, were significantly higher for the 
pooled tumor vessels than for the control vessels (see Figure 3). Nearly all of the tumors 
exhibited enhancement over the normal tissue, with the mean difference of 24.6 between the 
normal and tumor tissue VVD. Using a paired t-test, the difference between VVD in the 
tumor (μ = 43.8 ± 21.5) and surrounding tissue (μ = 19.5 ± 18.0) is significant, with p<0.01. 
The mean and standard deviation DM of the control vessels was 1.255 ± 0.371, whereas the 
combined tumor groups showed an elevated DM (p<0.01) with a mean and standard 
deviation of 1.431 ± 0.596, representing an increase in the mean of approximately 14%. The 
control vessels have a mean SOAM of 22.51 ± 9.45, while the SOAM of the combined 
tumor groups is increased roughly 60% from the control condition (p<0.01), with a mean of 
35.92 ± 13.49.
Additionally, comparing the DM and SOAM between control vessels and the vessels from 
each of the size classifications (2-3 mm, 3-4 mm, and >4 mm) using a two-sided T-test, 
there is a significant difference between the control group using a cutoff of p< 0.0167 to 
represent a significance level of α=0.05 with a Bonferroni correction to account for multiple 
hypothesis testing. Table 1 shows summary statistics of each size group and control vessels, 
including the median, mean, and standard deviation for both tortuosity metrics, as well as 
number of vessels analyzed and tumor size ranges. Tukey boxplots (Figure 4), in which the 
box defines the interquartile range (IQR) and the median, and the whiskers are located at the 
points 1.5 times the IQR, of the DM and SOAM show the trend of tortuosity increasing with 
tumor size, and reaching a plateau for tumors larger than 4 mm. This trend is also visible in 
Figure 5, by plotting the mean tortuosity metric of each of the 24 tumors versus size. Linear 
least-squares regression analysis shows positive correlation for both the DM (R2=0.26) and 
SOAM (R2=0.07), but only the trend relating tumor diameter to the distance metric is 
statistically significant (p<0.01).
Discussion
Acoustic angiography represents a substantial advance in ultrasound imaging technology 
and allows for meaningful quantification of vascular structure for evaluation of disease 
involving vascular dysfunction, especially cancer, as presented here. This method uses a 
standard FDA approved contrast agent (albeit off-label currently), and a new type of 
ultrasound imaging transducer designed to have a bandwidth much broader than existing 
single-frequency transducers. The acoustic pressure and frequency required for this 
Shelton et al. Page 6













technique is within FDA limits as well as within the mechanical index recommendation of 
0.8 for the clinical use of Definity® (Lantheus Medical Imaging, N. Billerica, MA). 
Although the mechanical index (MI) used in this study is above the “low MI” scheme 
frequently used for contrast imaging (Kim et al. 2008), higher pressures are required to 
produce optimal contrast to tissue ratios in acoustic angiography (Gessner et al. 2010; 
Lindsey et al. 2014). However, contrast imaging techniques with mechanical indices greater 
than used here, such as flash-replenishment, have been used safely in clinical practice for 
several years (Aggeli et al. 2008; Dolan et al. 2009).
We have shown that two metrics of tortuosity, the distance metric and sum of angles metric, 
are both increased in tumors at least 2mm in their largest dimension. The DM best describes 
low-frequency deviations from straight, such as vessels that grow in arching curves, whereas 
the SOAM accurately quantifies tortuosity of high frequency variations that represent 
locations of high local curvature, without greatly increasing the total length of a vessel. Both 
descriptions of vessel structure show an increasing trend as tumors increase in size, with the 
SOAM measurements showing greater magnitude changes between groups. Interestingly, 
the tortuosity metrics of the largest group (>4 mm tumors), which include tumors between 4 
and 7 mm, seem to plateau, though variability in mean tortuosity between tumors weakens 
the correlations between size and tortuosity. The apparent tortuosity plateau may be due to 
the angiogenic signaling and neovascularization processes reaching a maximum level at this 
size for the tumor type studied. However, another likely explanation is that tumors over 4 
mm in diameter become more noticeably heterogeneous. The variation in the location of 
tumor growth can cause differences in proximity to native vasculature, and thus have an 
influence on anisotropic patterns of angiogenesis. Additionally, these tumors tend to exhibit 
necrosis and/or hemorrhage as they continue to grow, and heterogeneous patterns of 
enhancement are visible in the acoustic angiography images as the tumors become larger. 
This heterogeneity in growth and vascularization is likely to also produce heterogeneity in 
vessel tortuosity. Both the DM and SOAM data from acoustic angiography images indicated 
abnormally high tortuosity at all stages of tumor evolution studied here, therefore we can 
hypothesize that these morphological differences are due to malignant angiogenesis, not a 
wound healing response from tumor initiation or other potential artifacts of a xenograft 
model that could contribute to angiogenesis in implanted tumor models.
Since tumor angiogenesis is common to nearly all tumor types and across species, the 
quantification of vascular abnormalities provides a powerful tool for studying cancer. The 
vessel structures visible in acoustic angiography images, and the tortuosity metrics derived 
therefrom, provide a clear distinction of small tumors from controls and are also sensitive to 
the evolution of vascular morphology that occurs during tumor growth in a pre-clinical 
model. Thus, the ability to directly image these blood vessels in humans would provide a 
powerful clinical tool for detecting early malignant lesions, evaluate early tumor treatment 
response, or possibly define tumor margins. Traditional clinical imaging modalities are 
unable to directly image the newly formed blood vessels at the necessary resolutions. 
Contrast enhanced computed tomography (CT) can demonstrate abnormal tissue 
enhancement, but is incapable of directly visualizing the vessels. Higher resolution CT 
techniques could be performed, but only at excessive radiation doses only appropriate for 
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specimens. Ultrasound power Doppler can also be performed to obtain perfusion type 
information, but clear microvascular structure is not visible.
Thus, we anticipate that acoustic angiography, which can directly image the tumor vessels 
with high resolution and contrast, can be used in adjunct to conventional imaging. The 
design of new transducers for human imaging will include the selection of new transmit and 
receive frequencies to achieve deeper, more clinically relevant imaging depths, at the 
expense of resolution, a topic recently explored by our group (Lindsey et al. 2014). For 
example, one potential application is to increase the specificity of breast ultrasound. Breast 
ultrasound is well known to be sensitive, but not specific in the evaluation of breast lesions, 
even with the use of advanced tools. However, by performing acoustic angiography during 
the same imaging session, one could theoretically evaluate if a lesion is a malignant or 
benign by visualizing the microvascular architecture within and surrounding the lesion. This 
approach could potentially improve our ability to characterize indeterminate lesions.
Another potential application is in the early evaluation of neoadjuvant therapy response. 
Early detection of tumor treatment response to chemotherapy is an important diagnostic 
question that could reduce inefficiencies of non-therapeutic or resistant therapies. MRI 
based approaches have been proposed, but are significantly more costly than ultrasound 
based techniques. Conventional ultrasound is primarily used to evaluate lesion size, but 
offers little information on the physiological status of the tumor. In this regard, acoustic 
angiography could potentially offer a low cost bedside support to serially evaluate tumor 
physiology and response to treatment.
One notable finding was that even the smallest tumors imaged in this work (2-3 mm in their 
largest dimension) had substantially higher tortuosity than control tissue, with statistical 
significance of p<0.01 for both the distance metric and sum of angles metric. This data 
suggests that it may be possible to detect sub-palpable tumors with acoustic angiography. 
Data also illustrates increasing measurements of microvascular tortuosity with increasing 
tumor size, indicating angiogenic abnormalities correlate with tumor progression. It is 
notable that acoustic angiography cannot directly visualize angiogenesis at the capillary 
scale, as vessels on the tens of microns scale are not resolvable with this technique (using 
the 30 MHz receiver configuration). However, vessel remodeling due to tumor angiogenesis 
has been observed in vasculature through a wide range of scales (Li et al. 2000; Jain 2003; 
Bullitt et al. 2004; Bullitt et al. 2007; Ungersma et al. 2010). Intravital microscopy imaging 
has demonstrated vessels close to 100 microns in diameter rapidly becoming tortuous upon 
injection of only 10s of tumor cells (Li et al. 2000). Although, the structure of early, small-
scale angiogenic processes such as sprouting angiogenesis is not resolvable with this 
technique, acoustic angiography images reinforce the observation that tortuous vessel 
growth and remodeling occurs at multiple scales, including many vessels at least 100-200 
microns in diameter that are resolvable during different stages of tumor evolution using 
acoustic angiography. Figure 6 shows serial imaging of tumors between 2.3 and 5.6 mm 
from two representative animals. Since both tortuosity metrics showed significant variation 
between animals, it is likely that clinical applications of acoustic angiography will include 
serial imaging to evaluate tortuosity changes during or after treatment, as has been done 
previously with MRI angiography in glioblastoma (Bullitt et al. 2009).
Shelton et al. Page 8













Major limitations of acoustic angiography include the limited depth of penetration, <2 cm in 
depth with the configuration here (although increased depth should be achievable with 
reduced resolution), and limited field of view. Field of view is limited to a small volume 
compared to CT or MRI, typically several cubic centimeters, as defined by the transducer 
configuration. Brain imaging or imaging near significant bone or gas interfaces is not 
possible to strong acoustic reflections which clutter the signal. Acoustic angiography also 
requires 3-D imaging to enable effective microvascular analysis. We currently reconstruct 3-
D volumes using a transducer mechanically scanned in the elevational axis, which increases 
time of the imaging scan and makes the imaging technique susceptible to tissue motion, 
although future 2-D matrix arrays could make volumetric acoustic angiography real-time. 
Frame rate is also limited using the current prototypes, because the dual single-element 
transducer design must swing across the tissue to acquire a B-mode image. Acoustic 
angiography is a contrast ultrasound technique, and despite a large body of safety data (Wei 
et al. 2008; Dolan et al. 2009; Fine et al. 2014), contrast agents still have limited regulatory 
agency approval, with most applications outside of cardiology being off-label. Finally, the 
dual-frequency broadband transducers required for high-resolution, high signal-to-noise 
acoustic angiography still only exist as a handful of prototypes. However, fabrication of 
newer dual-frequency array devices and clinical studies of acoustic angiography in patients 
are underway, and will provide more information as to the ultimate clinical utility of this 
technique in the near future.
Conclusions
The data presented here is the first application of acoustic angiography in small (2-7 mm) 
tumors, and the spontaneous, autochthonous mammary tumors in the C3(1)/Tag mice 
imaged in this study may provide a more relevant model of cancer angiogenesis than 
xenograft implants since tumorogenesis occurs due to tumor suppressor gene inactivation 
instead of implantation of foreign tissue (typically on the order of 106 cells). Enhancement 
in acoustic angiography images was quantified as volumetric vascular density, which was 
shown to be significantly elevated in tumor tissue compared to control tissue adjacent to 
tumors. Additionally, two quantifications of vessel morphology, the distance metric and sum 
of angles metric show increased tortuosity for small 2-3 mm tumors, relative to control 
animals and these metrics tend to increase with tumor size, eventually reaching a plateau. 
The unique information gained from dual-frequency, acoustic angiography provides an 
exciting new tool for studying tumor growth and angiogenesis in pre-clinical models, and 
may eventually benefit clinical patients with pathologies involving vascular dysfunction.
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Panel A shows a coronal slice reconstruction of a B-mode tissue volume. Panel B shows a 
maximum intensity projection of the acoustic angiography image of the same tissue volume, 
approximately 2.5 by 2.5 cm. The dashed outline delineates a tumor in the right inguinal 
mammary pad of a mouse in both images. The scale bar for both images is 4 mm.
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Orthogonal views (single slice) of a representative tumor in acoustic angiography: Panel A 
shows the axial view, panel B the sagittal, and panel C the coronal (rotated 90 degrees 
counterclockwise). The scale bar represents 3 mm.
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Tukey boxplots comparing the volumetric vascular density (panel A), distance metric (panel 
B), and sum of angles metric (panel C) in tumors vs. controls. P<0.01.
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Quantifications of vascular tortuosity by tumor size classification: Panel A shows Tukey 
boxplots of the distance metric (DM) for control vessels and 3 different sizes of tumors. 
Panel B shows Tukey boxplots of the corresponding sum of angles metric (SOAM) for the 
same sets of vessels. Each tumor group is statistically different from the control group 
(p<0.0167, Bonferroni corrected).
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Tumor size vs. the mean tortuosity metric with the least-squares regression line displayed 
for the 24 tumors analyzed. Panel A shows the distance metric, and panel B shows the sum 
of angles metric.
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Top row is animal 1: Panels A and B are acoustic angiography maximum intensity 
projections (MIPs) acquired 9 days apart. The tumor indicated by the dashed circle grew 
from 2.3 mm to 4.13 mm. Panel C shows a coronal B-mode image taken with panel B. 
Bottom row is animal 2: Panels D and E are acoustic angiography coronal MIPs acquired 7 
days apart, and panel F is a B-mode image corresponding to panel E. The tumor circled 
grew from 3.8 mm to 5.6 mm. All scale bars show 4 mm, and dashed circles indicate 
approximate tumor locations.
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Table 1
Summary Statistics for Vessel Segmentation and Tortuosity Analysis in Controls and Tumors
Controls 2-3mm 3-4mm >4mm
Average Tumor Size (mm) NA 2.47 3.52 5.24
Minimum Tumor Size (mm) NA 2.02 3.01 4.13
Maximum Tumor Size (mm) NA 2.93 3.92 6.86
Number of Vessels 1556 147 293 306
DM-Median 1.141 1.229 1.240 1.245
DM-Mean 1.255 1.404 1.401 1.473
DM-Standard Deviation 0.371 0.576 0.514 0.672
SOAM-Median 20.91 31.92 36.17 35.14
SOAM-Mean 22.51 32.89 37.49 35.87
SOAM-Standard Deviation 9.45 14.30 14.57 11.69
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